Leidos Holdings Inc
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Leidos Holdings Inc (LDOS). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| National Security & Digital | – | – | $6.70B 46.9% | $7.14B 46.6% · +6.6% | $7.30B 44.1% · +2.3% | $7.56B 44.2% · +3.5% |
| Health & Civil | – | – | $3.91B 27.4% | $4.20B 27.4% · +7.4% | $4.99B 30.1% · +18.8% | $5.05B 29.5% · +1.2% |
| Commercial & International | – | – | $1.87B 13.1% | $2.12B 13.8% · +13.4% | $2.25B 13.6% · +6.2% | $2.31B 13.5% · +2.8% |
| Defense Systems | – | – | $1.81B 12.6% | $1.88B 12.2% · +4.0% | $2.03B 12.2% · +8.0% | $2.18B 12.7% · +7.3% |
| Defense Solutions | $7.34B 60.2% | $8.03B 59.0% · +9.4% | – | – | – | – |
| Civil | $2.90B 23.8% | $3.04B 22.4% · +4.9% | – | – | – | – |
| Health | $1.96B 16.0% | $2.54B 18.7% · +30.1% | – | – | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Revenue by region
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| United States | $11.19B 91.8% | $12.47B 91.6% · +11.4% | $13.10B 91.7% · +5.0% | $14.02B 91.4% · +7.0% | $15.21B 91.7% · +8.5% | $15.70B 91.8% · +3.3% |
| International | $1.00B 8.2% | $1.15B 8.4% · +14.5% | $1.19B 8.3% · +3.6% | $1.32B 8.6% · +11.4% | $1.37B 8.3% · +3.5% | $1.40B 8.2% · +2.5% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 10, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.